Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells

  • Yan-Fang Tao1,
  • Jun Lu1,
  • Xiao-Juan Du2,
  • Li-Chao Sun3,
  • Xuan Zhao4,
  • Liang Peng5,
  • Lan Cao1,
  • Pei-Fang Xiao1,
  • Li Pang1,
  • Dong Wu1,
  • Na Wang1,
  • Xing Feng1,
  • Yan-Hong Li1,
  • Jian Ni6,
  • Jian Wang1Email author and
  • Jian Pan1Email author
Contributed equally
BMC Cancer201212:619

DOI: 10.1186/1471-2407-12-619

Received: 29 August 2012

Accepted: 21 December 2012

Published: 26 December 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
29 Aug 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Sep 2012 Author responded Author comments - Jian Pan
Resubmission - Version 3
10 Sep 2012 Submitted Manuscript version 3
20 Nov 2012 Reviewed Reviewer Report - Wei Zhang
28 Nov 2012 Reviewed Reviewer Report - Xiaoli Du
16 Dec 2012 Author responded Author comments - Jian Pan
Resubmission - Version 4
16 Dec 2012 Submitted Manuscript version 4
Publishing
21 Dec 2012 Editorially accepted
26 Dec 2012 Article published 10.1186/1471-2407-12-619

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Hematology and Oncology, Children's Hospital of Soochow University
(2)
Department of Gastroenterology, the 5th Hospital of Chinese PLA
(3)
Department of Cell and Molecular Biology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College
(4)
Beijing Insititute for Drug Control
(5)
Institute of Clinical Medical Science, China-Japan Friendship Hospital
(6)
Translational Research Center, Second Hospital, The Second Clinical School, Nanjing Medical University

Advertisement